Medicine Left Women Out of Drug Trials for 16 Years
The Fact
In 1977, the U.S. Food and Drug Administration issued guidance recommending that women of childbearing potential be excluded from early-phase drug trials. That policy approach remained influential until 1993, when federal policy changed toward greater inclusion of women in clinical research.
What This Means
For a significant period of modern drug development, women of reproductive age were routinely excluded from important phases of clinical testing. That matters because drug safety, dosing, metabolism, and adverse effects can differ by sex.
Sources
U.S. Food and Drug Administration. General Considerations for the Clinical Evaluation of Drugs. HEW Publication No. (FDA) 77-3040. September 1977.
U.S. Food and Drug Administration. “Guideline for the Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs.” Federal Register 58, no. 139 (July 22, 1993): 39406–39416.
